Supported by studies and advanced manufacturing processes
"Firstly, the rapid weight loss induced by GLP-1 agonists may alter hormone levels, which could affect vaginal lubrication and tissue health
Not only did different animal models such as rats, mice, rabbits and hamsters, help in the discovery and understanding of the therapeutic pathway of GLP-1 drugs, but they also provided crucial data on drug safety, pharmacokinetics and organ-specific effects, all of which were necessary for achieving regulatory approval and the successful translation to human use
Deacon S, English J, Arendt J
[4] About the Manufacturer Institute BCN Laboratory Institute BCN is operated by InstituteE BCN ESTHETICS S.L., a Barcelona-based laboratory specializing in mesotherapy and aesthetic solutions for professional clinical use
HUBERMAN: Now there's another hormone called IGF-1 or insulin growth factor one, which is produced by the liver